JPRN-UMIN000015300已完成未知
Study of effectiveness of the switch from Gn-RH agonist to degarelix for patients with prostate cancer as a second-line hormone therapy - FELIX Switch from Gn-RH agonist to degarelix on CRPC
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •Patients 1)who have a treatment history of degarelix 2)who have a treatment history of Enzalutamide or Abraterone 3)who are using steroid 4)who are using estrogen 5)who are using 5-alpha-reductase inhibitor 6)who have a serious cardiovascular disease 7)who have in active cancer except prostate cancer 8)have an allergy to degarelix 9)who are disqualified by a doctor in charge
研究者
相似试验
已完成
不适用
The evaluation of the efficacy of a switch from GnRH agonist to GnRH antagonist in prostate cancer patients who relapsed during combined androgen blockade.prostate cancerJPRN-UMIN000013514Tokai Urological Clinical Trial Group50
进行中（未招募）
不适用
Efficacy and pharmacokinetics of a switch from a regimen consisting of emtricitabine, nevirapine and tenofovir to rilpivirine, emtricitabine and tenofovir in virologically suppressed HIV-1 infected patients.EUCTR2012-001142-18-NLErasmus MC50
招募中
3 期
Comparison of the effectiveness of GnRH agonist stop-Antagonist protocol versus GnRH antagonist protocol in IVF candidate patientsIRCT20110731007165N10Tehran University of Medical Sciences74
尚未招募
4 期
To compare the success rate of Stop GnRH agonist-antagonist protocol with conventional IVF protocolsCTRI/2023/10/058780All India Institute of Medical Sciences, New Delhi
已完成
不适用
Investigation of the effects of switching to a high genetic barrier protease inhibitor based regimen on low level viremia, immune activation and neurocognitive performance in patients on antiviral therapyaidsHIV1002146010047438NL-OMON44785niversitair Medisch Centrum Utrecht65